Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q4 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $13 million versus the consensus estimate of $12.97 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

Earnings